AU587299B2 - Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug - Google Patents

Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug

Info

Publication number
AU587299B2
AU587299B2 AU65709/86A AU6570986A AU587299B2 AU 587299 B2 AU587299 B2 AU 587299B2 AU 65709/86 A AU65709/86 A AU 65709/86A AU 6570986 A AU6570986 A AU 6570986A AU 587299 B2 AU587299 B2 AU 587299B2
Authority
AU
Australia
Prior art keywords
topical administration
steroidal anti
inflammatory drug
adhesion formation
surgical adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU65709/86A
Other languages
English (en)
Other versions
AU6570986A (en
Inventor
Gere S. Dizerega
Douglas B. Johns
Leroy L. Richer
Shalaby W. Shalaby
Warren D. Sheffield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of AU6570986A publication Critical patent/AU6570986A/en
Application granted granted Critical
Publication of AU587299B2 publication Critical patent/AU587299B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65709/86A 1985-11-27 1986-11-26 Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug Expired AU587299B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80254585A 1985-11-27 1985-11-27
US802545 1985-11-27
US90012286A 1986-08-25 1986-08-25
US900122 1986-08-25

Publications (2)

Publication Number Publication Date
AU6570986A AU6570986A (en) 1987-06-04
AU587299B2 true AU587299B2 (en) 1989-08-10

Family

ID=27122463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65709/86A Expired AU587299B2 (en) 1985-11-27 1986-11-26 Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug

Country Status (7)

Country Link
EP (1) EP0225162B1 (OSRAM)
JP (1) JPH0798755B2 (OSRAM)
KR (1) KR940006321B1 (OSRAM)
AU (1) AU587299B2 (OSRAM)
DE (1) DE3683606D1 (OSRAM)
GR (1) GR3003915T3 (OSRAM)
YU (1) YU46032B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
WO1991012026A1 (en) * 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
DK0560900T3 (da) * 1990-12-03 1995-05-08 Nexstar Pharmaceuticals Inc Forebyggelse af synovialadhæsioner
US5583114A (en) 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
USRE38827E1 (en) 1994-07-27 2005-10-11 3M Innovative Properties Company Adhesive sealant composition
GR1003359B (el) * 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
WO2001051032A2 (en) * 2000-01-14 2001-07-19 Brown University Research Foundation Micronized freeze-dried particles
WO2004078210A1 (ja) 2003-03-06 2004-09-16 Takashi Muramatsu 開腹手術後の癒着の予防剤
US9066912B2 (en) * 2003-11-17 2015-06-30 Ethicon, Inc. Drug-enhanced adhesion prevention
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
ES2330295B1 (es) * 2008-06-06 2010-09-23 Laboratorios Alcala Farma, Sl Formulacion topica de ibuprofeno.
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2344290A1 (fr) * 1976-03-19 1977-10-14 Ici Ltd Nouvelles compositions pharmaceutiques anti-inflammatoires
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2344290A1 (fr) * 1976-03-19 1977-10-14 Ici Ltd Nouvelles compositions pharmaceutiques anti-inflammatoires
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation

Also Published As

Publication number Publication date
YU202886A (en) 1988-06-30
AU6570986A (en) 1987-06-04
GR3003915T3 (OSRAM) 1993-03-16
EP0225162B1 (en) 1992-01-22
YU46032B (sh) 1992-12-21
EP0225162A2 (en) 1987-06-10
JPH0798755B2 (ja) 1995-10-25
EP0225162A3 (en) 1987-11-19
DE3683606D1 (de) 1992-03-05
KR940006321B1 (ko) 1994-07-16
KR870004703A (ko) 1987-06-01
JPS62155223A (ja) 1987-07-10

Similar Documents

Publication Publication Date Title
ZA868964B (en) Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
AU587299B2 (en) Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug
AU587787B2 (en) Osmotic system for delivering drug to colon
ZA827898B (en) A compound having analgesic,anti-inflammatory and muco-regulatory activity,a method for the preparation thereof and related pharmaceutical compounds
AU4926485A (en) Anti-inflammatory/anti-allergic compounds
AU7185887A (en) Medication clock
IT8547924A0 (it) Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
AU4653385A (en) Analgesic 1,2-Benzisothiazol-3-ylpiperazine derivatives
AU5796286A (en) Form for forming concrete
AU587997B2 (en) Osmotic system for delivering drug to the colon
AU5824786A (en) Nasal inserts for the administration of pharmaceuticals
GB2180750B (en) Topical analgesic anti-inflammatory composition
AU5400186A (en) Analgesic composition
AU586306B2 (en) Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
AU576685B2 (en) Chromoglycic acid derivatives
AU584678B2 (en) Analgesic composition
AU5948286A (en) Anthranilic acid derivatives
AU571980B2 (en) Self-adhesive plaster for transdermal administration
AU7711987A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
AU5261886A (en) Coated dosage forms
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
FI864615A7 (fi) Menetelmä farmakologisesti aktiivisten -(aminoalkyyli)-aryylietikkahappojohdannaisten valmistamiseksi.
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
AU6656886A (en) Pharmaceutical composition of suprofen
AU528433B2 (en) Anti-inflammatory immunoregulatory pyridine derivatives